fluid was demonstrated in patients with COPD compared significant chronic inflammation in the pulmonary compartment with control subjects (11, 12) , reflecting neutrophilia in the as well as in the circulation. This study aimed to elucidate the relacentral airways (13). The extent of neutrophilia correlated tionship between local and systemic inflammation in smoking-inwith the degree of airflow limitation (12, 14, 15) . Analysis of 
mains of the TNF receptors. Therefore, soluble TNF (sTNF) tor receptors receptors are often considered as markers of a proinflammatory state. Chronic obstructive pulmonary disease (COPD) is characterBesides the presence of chronic local inflammation in the ized by the progressive development of airflow limitation respiratory organ, there is increasing evidence of systemic that is not fully reversible (reviewed in Reference 1). The inflammation in patients with stable disease as well as during main risk factor for COPD is cigarette smoking, and at presepisodes of acute exacerbations. Recent studies demonent, cessation of smoking is the only intervention with a strated that levels of sTNF-R55 and sTNF-R75 were signifisignificant attenuation of the degree of lung function impaircantly increased in the circulation of patients with COPD ment (2-4). There is increasing evidence that COPD is associ- (24) (25) (26) (27) (28) . The presence of a systemic inflammatory response ated with a chronic inflammatory response in both airways has an important influence on the quality of life as weight and lung parenchyma. Histopathologic studies have shown loss and muscle wasting are linked to systemic inflammation that patients with COPD have increased numbers of macro- (24, (28) (29) (30) . The main cause for the presence of systemic phages and CD8ϩ T cells in the peripheral airways and lung inflammation in patients with COPD still remains to be eluciparenchyma (5) (6) (7) (8) , which may be associated with latent adedated. Systemic hypoxia is suggested to be a good candidate, noviral infection (9, 10) . On the other hand, a marked inas systemic hypoxia is associated with activation of the TNF-␣ crease in neutrophils in sputum and bronchoalveolar lavage system in patients with COPD (27). However, no information is yet available comparing the local inflammatory involvement in the respiratory organ with the presence of a systemic inflammatory response in COPD. In addition, except for (Received in original form February 11, 2002 ; accepted in final form August 15, 2002) elevation of TNF-␣ in sputum of patients with COPD, no
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information is currently available about sTNF receptors in
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sputum of patients with COPD. Therefore, this study is diVernooy, M.Sc., Department of Pulmonology, University Hospital Maastricht, rected at unraveling the relationship between local and sys-assessed. To this end, subjects were divided according to their
Analysis of sTNF Receptors, TNF-␣, and IL-8 Levels in Sputum current smoking status, and levels of inflammatory mediators and Plasma in induced sputum and plasma were compared between cursTNF-R55 and sTNF-R75 assays. sTNF-R were measured in sputum rent smokers and ex-smoking individuals who completely supernatant and plasma using specific sandwich enzyme-linked immunosorbent assay (ELISA) as described (32, 33) . Rabbit anti-human abstained for at least 1 year.
sTNF-R55 polyclonal antibody and murine anti-human sTNF-R75 monoclonal antibody (MR2-2) were used as coating antibodies. Assays
METHODS
for sTNF-R were not affected by presence of TNF (33) , indicating that total amounts of sTNF-R55 and sTNF-R75 (free and bound to TNF-␣) Subjects were measured. The lower detection limit was 60 pg/ml for sTNF-R55 Eighteen patients with smoking-related, clinically stable COPD foland 30 pg/ml for sTNF-R75. lowed up by general practitioners participated in the study. All of the TNF-a assays. Levels of TNF-␣ were measured using (1 ) a specific patients met American Thoracic Society criteria for the diagnosis of sandwich ELISA as described previously (34, 35) that recognizes bioac-COPD (31) . Inclusion criteria for patients with COPD included stable tive TNF-␣ with a lower detection limit of 15 pg/ml as well as by (2 ) airflow limitation with an FEV 1 of less than 70% predicted with reversa commercially available ELISA (HyCult Biotechnology BV, Uden, ibility of less than 11% predicted FEV 1 or less than 200 ml after inhaled
The Netherlands) that recognizes free TNF-␣ as well as TNF-␣ bound ␤-agonist administration and a previous history of at least 20 packto sTNF receptors (referred to as total TNF-␣ fraction; personal communication HyCult Biotechnology BV) with a lower limit of detection years of smoking. Six subjects with COPD were ex-smokers who had of 20 pg/ml. quit smoking for at least 1 year before the start of the study. Regular IL-8 assay. IL-8 levels were determined using specific sandwich use of inhaled steroids was considered as an exclusion criterion for ELISA as described by Bouma and colleagues (36) . The lower detection participation to the study: none of the studied patients with COPD limit was 8 pg/ml. therefore used inhaled steroids. Thirteen patients were prescribed com-DTT effect. To study the effect of DTT on ELISA determination bination therapy (fenoterol/ipratropiumbromide) on a regular basis.
of the inflammatory mediators assessed, standard curves of appropriate Two patients were on long-acting ␤ 2 -agonists, and all other patients recombinant proteins were incubated with 0.1% DTT (Sputolysin) unwere prescribed bronchodilating agents on demand. Furthermore, a der the same conditions as sputum samples during processing (20 minhistory of respiratory diseases other than COPD as well as increased utes at room temperature). The presence of DTT resulted in less than respiratory complaints or respiratory tract infection during 4 weeks 5% inhibition of the detection of sTNF-R55 and IL-8 by ELISA and preceding the study was considered a criterion for exclusion. A control less than 10% inhibition in case of sTNF-R75, bioactive TNF-␣, and group of so-called healthy smokers was recruited that consisted of 17 total TNF-␣ fraction, indicating that DTT has little or no effect on the subjects with a normal FEV 1 and no medical history of lung disease. assays used in this study (data not shown). A smoking history of at least 15 pack-years was used as criterion for inclusion. Seven control subjects were ex-smokers. The control subMicrovascular Leakage jects lived in the same geographic area as the patient population. The Microvascular leakage was determined in each individual as follows: study was approved by the medical ethics committee of the University sputum albumin (mg/L)/serum albumin (g/L). The albumin concentraHospital of Maastricht. Written informed consent was obtained from tion in sputum and plasma was measured using a newly developed all subjects.
ELISA. Immunomaxisorp plates (Nunc, Roskilde, Denmark) were coated overnight with albumin-specific monoclonal antibody 4D5 Pulmonary Function Test and Blood Sampling (HM17). Diluted plasma samples and a standard dilution series with FEV 1 was measured by trained lung function technicians using a spiromhuman albumin (Sigma, St. Louis, MO) were added to the plate. Albueter (Masterlab; Jaeger, Wü rzburg, Germany) before and 15 minutes min was detected with a horseradish peroxidase-labeled polyclonal rabbit anti-human albumin immunoglobulin G (Cappel; Organon Tekafter inhalation of ␤-agonist via a metered-dose inhaler. Blood samples nika Corporation, West Chester, PA) followed by 3Ј,5,5Ј-tetramethwere collected in evacuated blood collecting tubes containing ethyleneylbenzidine (Kirkegaard and Perry Lab, Gaithersburg, MD) as subdiaminetetraacetic acid (Sherwood Medical, St. Louis, MO) before spustrate. The lower detection limit was 10 ng/ml. The presence of DTT tum induction (8:00 to 10:00 a.m.). Plasma samples were stored at Ϫ80ЊC resulted in a less than 5% inhibition of the detection of albumin by until analyzed.
ELISA.
Sputum Induction and Processing
Statistical Analysis Sputum was induced after a procedure as reported elsewhere (14) .
Results are presented as mean Ϯ SD for normally distributed variables Briefly, subjects inhaled 3% hypertonic saline, nebulized via an ultraand median (range) otherwise. Groups were compared by analysis sonic nebulizer (NEB2000; TEFA-Portanje, Woerden, The Netherof covariance adjusted for age, sex, or pack-years where appropriate. lands) during three 7-minute periods. Before expectoration, subjects Nonparametric data were compared by the Mann-Whitney U test. The were instructed to mouthwash thoroughly with saline solution to minichi-square test was used to compare categorical variables. Correlations mize saliva contamination. The collected sputum was pooled and kept between parameters were evaluated using Pearson's rank correlation at 4ЊC for not more than 2 hours before further processing.
analysis (Statistical Package for the Social Sciences, version 10.0 for The volume of the pooled sputum (without selection of sputum Windows; SPSS Inc., Chicago, IL). A p value of less than 0.05 denotes plugs) was recorded, and an equal volume of 0.2% dithiothreitol (DTT; the presence of a significant statistical difference. Sputolysin; Calbiochem, La Jolla, CA) was added. The samples were then mixed gently by a vortex mixer and incubated for 20 minutes
RESULTS
at room temperature to ensure complete homogenization. Cell-free supernatants were frozen at Ϫ80ЊC until subsequent analysis. The total Clinical Characteristics cell count and cell viability were assessed using a standard hemocytomeClinical characteristics of patients with COPD and healthy smokter (Coulter Z1; Coulter Electronics, Mijdrecht, The Netherlands) and ers are shown in Table 1 . Patients with COPD had significant by trypan blue exclusion, respectively. Cytospins were stained according airflow limitation, whereas control subjects had normal FEV 1 to the May-Grü nwald Giemsa method. Differential cell counts were values (percentage predicted) according to the selection criteria.
performed by one observer blinded to the clinical characteristics, counting 500 nucleated cells. The numbers of squamous epithelial cells were Sputum Characteristics subtracted, and the differential cell counts were expressed as corrected All subjects included in this study tolerated well the procedure percentages. A sample was considered adequate if the slides contained 15% or less squamous epithelial cells.
of sputum induction, and an adequate specimen of sputum was in both study groups. In contrast, sputum levels of the sTNFcollected in every participant. Induced sputum was analyzed for receptors strongly correlated with the percentage of neutrophils total and differential cell counts, as shown in Table 2 . The total in patients with COPD, but this was not the case in healthy cell counts and cell viability in sputum were not different in smokers. To address discrepancy, study groups were split acpatients with COPD versus healthy smokers. Neutrophils (percording to the level of sputum neutrophils using the mean ϩ centage) were significantly higher in patients with COPD in 1 ϫ SD of sputum neutrophils in healthy controls as cutoff point. comparison with control subjects, whereas macrophages (perAs shown in Figure 1 , neutrophils (percentage) in sputum of 11 centage) were significantly lower.
patients with COPD and 2 healthy smokers were out of the In addition, levels of the neutrophil chemoattractants IL-8 range of those found in healthy smokers. Furthermore, there and TNF-␣ were determined in the sputum supernatant. IL-8
was a large variance in sputum levels of sTNF-R55 and sTNFlevels were significantly elevated in patients with COPD com-R75 in patients with COPD with high neutrophil levels, whereas pared with healthy smokers (Table 3 ) and were strongly correthis was not the case in patients with COPD with low neutrophil lated with the number of neutrophils in the COPD group, but levels. not in the control group (Table 4) . Concerning TNF-␣, both Next, we investigated whether the pulmonary inflammation bioactive TNF-␣ and the total TNF-␣ fraction (free TNF-␣ and was related to the degree of airflow limitation. To this end, we TNF-␣ bound to sTNF receptors) were determined (Table 3) .
looked for correlations between the FEV 1 (percentage preBioactive TNF-␣ was not detected in sputum samples of either dicted) and sputum levels of IL-8, sTNF receptors, and TNF-␣. patients with COPD or healthy smokers. Using the assay for As shown in Figure 2 , sputum levels of IL-8 and sTNF-R55 the total TNF-␣ fraction, low concentrations of TNF-␣ were strongly correlated with airflow limitation in patients with COPD detected, but total TNF-␣ levels in sputum were not significantly but not in healthy smokers. Sputum sTNF-R75 levels tended to different between the two groups.
correlate with the FEV 1 in patients with COPD, but this did not To characterize further the local inflammation in COPD, reach the level of statistical significance (sTNF-R75, r ϭ Ϫ0.444, sputum levels of sTNF-R55 and sTNF-R75 were determined. p ϭ 0.08). The total TNF-␣ fraction in sputum was not related As shown in Table 3 , both sTNF receptors were detectable in to airflow limitation in patients with COPD (r ϭ Ϫ0.258, p ϭ induced sputum of patients with COPD and healthy smokers. 0.317). Sputum sTNF-R55 levels in patients with COPD patients showed a twofold increase as compared with healthy smokers. Sputum Plasma Levels of sTNF Receptors, TNF-␣, and IL-8 sTNF-R75 levels showed a tendency to increase in patients with Systemic inflammation was assessed by determination of plasma COPD, but did not reach the level of statistical significance (p ϭ levels of sTNF-R55, sTNF-R75, TNF-␣, and IL-8 by specific 0.08). As shown in Table 4 , sputum levels of sTNF-R55 and sTNF-R75 correlated highly with each other, and with IL-8 levels significantly increased in patients with COPD. Like in sputum, plasma levels of sTNF-R55 and sTNF-R75 correlated highly with each other in both patients with COPD (r ϭ 0.797, p Ͻ 0.001) of IL-8 in the COPD group. Circulating TNF-␣ was measured and healthy smokers (r ϭ 0.732, p ϭ 0.001). IL-8 was detectable using the assay for total TNF-␣. Plasma TNF-␣ levels of all inin 4 out of 18 patients with COPD in comparison with none of dividuals except two were below the lower detection limit of the assay. the 17 control subjects, resulting in significantly increased levels tion, sTNF-R55 and IL-8 levels in sputum from ex-smoking patients with COPD were also significantly raised in comparison with ex-smoking healthy subjects, whereas sTNF-R75 levels showed a tendency to increase in ex-smoking patients with In addition, we investigated whether the systemic inflamma-COPD (p ϭ 0.09). In contrast, circulating levels of all inflammation was related to the degree of airflow limitation by analyzing tory mediators assessed were not different in current smokers correlations between the FEV 1 (percentage predicted) and compared with ex-smokers in both study groups. plasma levels of IL-8 and sTNF receptors. In contrast to inflammatory mediators in sputum, circulating levels of the sTNF-
DISCUSSION
receptors and IL-8 did not show any correlation with the degree of airflow limitation (data not shown).
This study focused on the relationship between local and systemic inflammation in patients with mild-to-moderate smoking-
Relationship between Local and Systemic Compartment
related COPD. Analysis of induced sputum showed a significant To investigate the possible relationship between local and sysincrease in neutrophils (percentage) and IL-8 levels in patients temic inflammation in patients with COPD, we first determined with COPD versus healthy smokers, which correlated highly to what extent the data are affected by microvascular leakage.
with each other and with the degree of airflow limitation. These To this end, we measured albumin levels in sputum and plasma findings are in line with previous observations in patients with of patients with COPD and healthy smokers and calculated the COPD (11, 14, 16, 17) . Concerning TNF-␣, we found no signifilevel of microvascular leakage in each individual as follows:
cant differences in sputum TNF-␣ levels between mild-to-modersputum albumin (mg/L)/serum albumin (g/L). Sputum-to-plasma ate patients with COPD and healthy smokers using either an ratios of albumin were not significantly different between the ELISA that measures strictly intact TNF-␣ that is not bound by two study groups (median [range] COPD, 1.68 [0.41-6.11]; con-TNF-receptors or using an ELISA that detects the total TNF-␣ trol, 1.31 [0. .00], p Ͼ 0.05), indicating a similar degree of fraction, that is, free TNF-␣ and TNF-␣ bound to sTNF-R. In microvascular leakage in patients with COPD and healthy smokcontrast, Keatings and colleagues reported a rise in TNF-␣ levels ers. Therefore, the values of the inflammatory mediators in spuin induced sputum of patients with severe COPD (14) . This tum were not corrected for microvascular leakage. discrepancy may be due to differences in severity of COPD in Next, we looked for correlations between sputum and plasma the two patient populations studied or to differences between levels of sTNF-R55, sTNF-R75, and IL-8 in patients with COPD the characteristics of the TNF-␣ assays used. In addition, study and healthy smokers to examine the relationship between local populations may differ in rates of bacterial colonization, which and systemic inflammation. As shown in Table 6 , no direct correwas demonstrated to result in higher TNF-␣ levels in spontanelations were found between sputum and plasma concentrations ously expectorated sputum from Haemophilus influenzae-coloof each inflammatory mediator analyzed in either patients with nized patients with COPD in comparison with noncolonized but otherwise similar patients with COPD (37) . Finally, neutrophil COPD or in healthy smokers. elastase that is present in neutrophil microenvironment in inof the age-related decline in FEV 1 (2-4). However, a longitudinal duced sputum of patients with COPD is a potential parameter follow-up study of smoking-induced lung density changes by in the degradation of TNF-␣ into bioinactive TNF-␣ (38), which high-resolution computed tomography demonstrated that the may hamper the detection of bioactive TNF-␣ in sputum.
worsening airspace abnormality in the upper lung zones of smokSoluble receptors for TNF-␣ are considered to be markers ers did not slow down with cessation of smoking (42) . In addition, of a proinflammatory state because of their shedding from the other studies investigating airway inflammation reported that cell membrane in response to endogenous TNF-␣ and other smoking cessation did not influence the cellular profile and levels inflammatory mediators. In this study, we showed that in particuof IL-8 in central and peripheral airways (16, (43) (44) (45) . In this lar sTNF-R55 was increased in induced sputum of patients with study, we found a remarkable increase in sputum levels of sTNFmild-to-moderate COPD compared with healthy smokers, which R55, sTNF-R75, and IL-8 in ex-smoking patients with COPD correlated with airflow limitation as well as other inflammatory compared with currently smoking patients with COPD, but not markers (IL-8 and neutrophilia) in patients with COPD. Espein ex-smoking versus currently smoking healthy controls. In addicially respiratory epithelial cells are reported to express TNF-R55 tion, sputum levels of sTNF-R55 and IL-8 in ex-smoking patients (22) and may therefore account significantly for the increased with COPD were also significantly raised in comparison with levels of sTNF-R55 in sputum. In addition, in vitro studies by levels in ex-smoking healthy subjects. In contrast, the systemic Porteu and Nathan demonstrated that activation of neutrophils proinflammatory state was not associated with the smoking status resulted in shedding of both sTNF-receptors from the cell surin both study groups. Our results are strongly supported by the face, which suggests that sTNF-R55 and sTNF-R75 measured recently reported data of Willemse and colleagues (46), who in sputum may also be derived from activated neutrophils that collected induced sputum before and 1 year after smoking cessaare extensively present in sputum of patients with COPD (39) . tion in smokers with COPD and without COPD. They showed Previous studies from our group as well as other groups inthat IL-8 levels in sputum decreased without changes in sputum vestigating systemic inflammation in patients with COPD demneutrophils after 1 year of smoking cessation in smokers without onstrated small but significant increases in plasma levels of COPD. In contrast, in smokers with COPD, levels of IL-8 and sTNF-R55 and sTNF-R75 in patients with COPD in addition to neutrophils in sputum tended to increase (p Ͻ 0.1). Taken toenhanced levels of acute phase proteins (24) (25) (26) (27) (28) . In line with gether, these data suggest an ongoing inflammatory response these reports, we demonstrated that circulating sTNF-R75 levels in the respiratory compartment of patients with COPD after were elevated in patients with COPD as compared with healthy smoking cessation. smokers. The biologic significance in the sense of the role that In summary, patients with COPD had significantly higher such a difference plays in the biologic phenomenon is not clear percentages of neutrophils and increased levels of sTNF-R55 from these studies. sTNF receptors are known to compete for and IL-8 in their induced sputum samples as compared with TNF-␣ with the cell surface TNF receptors and may hereby play healthy smokers. A comparison of sTNF-receptors in sputum a role in regulating steady-state levels of TNF-␣ in the airways and plasma, however, did not demonstrate direct correlations and circulation (40) . Further studies using large study populabetween local and systemic inflammation, despite the signifitions are necessary to elucidate the origin of sTNF receptors and cantly higher circulating levels of sTNF-R75 in patients with their function-either proinflammatory or antiinflammatory-in COPD. Moreover, sputum sTNF receptors were related with chronic inflammation in COPD.
the degree of airflow limitation in patients with COPD, whereas Although it is generally accepted that systemic inflammation circulating sTNF receptors were not, suggesting different regulacontributes to the impaired health status in COPD, little is known tion of the inflammatory response in the local and systemic about the origin of the systemic inflammation. Therefore, we compartment. Sputum levels of sTNF-R55, sTNF-R75, and IL-8 assessed the possible relationship between the local and systemic were increased in ex-smoking versus currently smoking patients inflammatory response. First, results of this study showed that with COPD as well as ex-smoking control subjects, whereas the patients with COPD had increased levels of sTNF-R55 levels in current smoking status was not associated with the systemic sputum as compared with healthy smokers, whereas the reverse proinflammatory state in the study groups. These results confirm situation occurred in plasma: levels of sTNF-R75 were higher the presence of inflammatory processes in the airways and circuin patients with COPD than in control subjects. Second, we found lation of patients with COPD despite smoking cessation. no correlation between the individual inflammatory mediators in sputum compared with plasma in both study groups. Further-
